Page last updated: 2024-10-16

beta-alanine and Guillain-Barre Syndrome

beta-alanine has been researched along with Guillain-Barre Syndrome in 1 studies

Guillain-Barre Syndrome: An acute inflammatory autoimmune neuritis caused by T cell- mediated cellular immune response directed towards peripheral myelin. Demyelination occurs in peripheral nerves and nerve roots. The process is often preceded by a viral or bacterial infection, surgery, immunization, lymphoma, or exposure to toxins. Common clinical manifestations include progressive weakness, loss of sensation, and loss of deep tendon reflexes. Weakness of respiratory muscles and autonomic dysfunction may occur. (From Adams et al., Principles of Neurology, 6th ed, pp1312-1314)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, ZY1
Zhang, Z1
Zug, C1
Nuesslein-Hildesheim, B1
Leppert, D1
Schluesener, HJ1

Other Studies

1 other study available for beta-alanine and Guillain-Barre Syndrome

ArticleYear
AUY954, a selective S1P(1) modulator, prevents experimental autoimmune neuritis.
    Journal of neuroimmunology, 2009, Nov-30, Volume: 216, Issue:1-2

    Topics: Animals; B-Lymphocytes; beta-Alanine; Chemotaxis, Leukocyte; Disease Models, Animal; Guillain-Barre

2009